Coagulation Factor IX Conjugates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150225710A1
SERIAL NO

14620583

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to Factor IX polypeptides conjugated to heparosan (HEP) polymers, methods for the manufacture thereof and uses of such conjugates. The resultant conjugates may be used—for example—in the treatment or prevention of bleeding disorders such as haemophilia B.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVO NORDISK HEALTHCARE AGTHURGAUERSTRASSE 36/38 ZURICH CH-8050

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Behrens, Carsten Koebenhavn, DK 72 703
Deangelis, Paul L Edmond, US 63 348
Haller, Friedrich Michael Norman, US 6 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation